Search by Drug Name or NDC

    NDC 47335-0009-72 Tadalafil 2.5 mg/1 Details

    Tadalafil 2.5 mg/1

    Tadalafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is TADALAFIL.

    Product Information

    NDC 47335-0009
    Product ID 47335-009_5f176ab2-0dba-4418-8aee-27a110ed6396
    Associated GPIs 40304080000302
    GCN Sequence Number 063691
    GCN Sequence Number Description tadalafil TABLET 2.5 MG ORAL
    HIC3 F2A
    HIC3 Description DRUGS TO TREAT ERECTILE DYSFUNCTION (ED)
    GCN 99409
    HICL Sequence Number 024859
    HICL Sequence Number Description TADALAFIL
    Brand/Generic Generic
    Proprietary Name Tadalafil
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tadalafil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name TADALAFIL
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208934
    Listing Certified Through 2024-12-31

    Package

    NDC 47335-0009-72 (47335000972)

    NDC Package Code 47335-009-72
    Billing NDC 47335000972
    Package 1 BLISTER PACK in 1 CARTON (47335-009-72) / 15 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2019-03-26
    NDC Exclude Flag N
    Pricing Information N/A